These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12499248)

  • 21. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck.
    Neuchrist C; Erovic BM; Handisurya A; Fischer MB; Steiner GE; Hollemann D; Gedlicka C; Saaristo A; Burian M
    Head Neck; 2003 Jun; 25(6):464-74. PubMed ID: 12784238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of short-chain fatty acids on head and neck squamous carcinoma cells.
    Krishna S; Brown N; Faller DV; Spanjaard RA
    Laryngoscope; 2002 Apr; 112(4):645-50. PubMed ID: 12150517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of p53 or p27 overexpression on cyclooxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines.
    Lee DW; Park SW; Park SY; Heo DS; Kim KH; Sung MW
    Head Neck; 2004 Aug; 26(8):706-15. PubMed ID: 15287038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased NBS1 expression is a marker of aggressive head and neck cancer and overexpression of NBS1 contributes to transformation.
    Yang MH; Chiang WC; Chou TY; Chang SY; Chen PM; Teng SC; Wu KJ
    Clin Cancer Res; 2006 Jan; 12(2):507-15. PubMed ID: 16428493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma.
    Carvalho AL; Chuang A; Jiang WW; Lee J; Begum S; Poeta L; Zhao M; Jerónimo C; Henrique R; Nayak CS; Park HL; Brait MR; Liu C; Zhou S; Koch W; Fazio VM; Ratovitski E; Trink B; Westra W; Sidransky D; Moon CS; Califano JA
    Cancer Res; 2006 Oct; 66(19):9401-7. PubMed ID: 17018594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of vascular endothelial growth factor receptors on tumor cells in head and neck squamous cell carcinoma.
    Lalla RV; Boisoneau DS; Spiro JD; Kreutzer DL
    Arch Otolaryngol Head Neck Surg; 2003 Aug; 129(8):882-8. PubMed ID: 12925349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness.
    Jokilehto T; Rantanen K; Luukkaa M; Heikkinen P; Grenman R; Minn H; Kronqvist P; Jaakkola PM
    Clin Cancer Res; 2006 Feb; 12(4):1080-7. PubMed ID: 16489060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokeratins 6 and 16 are frequently expressed in head and neck squamous cell carcinoma cell lines and fresh biopsies.
    Sesterhenn AM; Mandic R; Dünne AA; Werner JA
    Anticancer Res; 2005; 25(4):2675-80. PubMed ID: 16080511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of growth and telomerase activity by novel cationic ceramide analogs with high solubility in human head and neck squamous cell carcinoma cells.
    Rossi MJ; Sundararaj K; Koybasi S; Phillips MS; Szulc ZM; Bielawska A; Day TA; Obeid LM; Hannun YA; Ogretmen B
    Otolaryngol Head Neck Surg; 2005 Jan; 132(1):55-62. PubMed ID: 15632910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidermal growth factor receptor-stimulated activation of phospholipase Cgamma-1 promotes invasion of head and neck squamous cell carcinoma.
    Thomas SM; Coppelli FM; Wells A; Gooding WE; Song J; Kassis J; Drenning SD; Grandis JR
    Cancer Res; 2003 Sep; 63(17):5629-35. PubMed ID: 14500405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolonged response to antisense cyclin D1 in a human squamous cancer xenograft model.
    Sauter ER; Herlyn M; Liu SC; Litwin S; Ridge JA
    Clin Cancer Res; 2000 Feb; 6(2):654-60. PubMed ID: 10690551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salivary soluble CD44: a potential molecular marker for head and neck cancer.
    Franzmann EJ; Reategui EP; Carraway KL; Hamilton KL; Weed DT; Goodwin WJ
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):735-9. PubMed ID: 15767360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Major histocompatibility gene therapy: the importance of haplotype and beta 2-microglobulin.
    Salamone FN; Gleich LL; Li YQ; Stambrook PJ
    Laryngoscope; 2004 Apr; 114(4):612-5. PubMed ID: 15064612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.
    Chung CH; Ely K; McGavran L; Varella-Garcia M; Parker J; Parker N; Jarrett C; Carter J; Murphy BA; Netterville J; Burkey BB; Sinard R; Cmelak A; Levy S; Yarbrough WG; Slebos RJ; Hirsch FR
    J Clin Oncol; 2006 Sep; 24(25):4170-6. PubMed ID: 16943533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC)--potential implications for clinical management and treatment decisions.
    Hass HG; Schmidt A; Nehls O; Kaiser S
    Oral Oncol; 2008 Jan; 44(1):78-85. PubMed ID: 17350326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotypic and microarray gene expression analysis of tri-dimensional raft-modeled human head and neck squamous cell carcinoma.
    Zanation AM; Yin X; Shores C; Yarbrough WG
    Otolaryngol Head Neck Surg; 2004 Nov; 131(5):577-84. PubMed ID: 15523429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increase in gene dosage is a mechanism of HIF-1alpha constitutive expression in head and neck squamous cell carcinomas.
    Secades P; Rodrigo JP; Hermsen M; Alvarez C; Suarez C; Chiara MD
    Genes Chromosomes Cancer; 2009 May; 48(5):441-54. PubMed ID: 19235921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
    Andrews GA; Xi S; Pomerantz RG; Lin CJ; Gooding WE; Wentzel AL; Wu L; Sidransky D; Grandis JR
    Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of LOX- and LOXL2-mRNA expression in head and neck squamous cell carcinomas.
    Rost T; Pyritz V; Rathcke IO; Görögh T; Dünne AA; Werner JA
    Anticancer Res; 2003; 23(2B):1565-73. PubMed ID: 12820424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneity of the proliferative fraction and cyclin D1/CCND1 gene amplification in head and neck squamous cell carcinoma.
    el-Naggar AK; Steck K; Batsakis JG
    Cytometry; 1995 Sep; 21(1):47-51. PubMed ID: 8529470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.